Packard BioScience Reports Jump in Q2 Revenues | GenomeWeb

NEW YORK, Aug 3 – Packard BioScience said its second-quarter revenues rose 27 percent to $49 million, compared with $38.6 million in the year-ago quarter, as revenues from liquid handling and automated sample preparation technologies rose.

During the quarter, service revenues, which had dropped over the past year, also increased 10 percent compared with the same period one year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.